Qvar Redihaler
Product Images NDC 53002-2436

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Qvar Redihaler (NDC 53002-2436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of QVAR REDIHALER's active ingredient, showing a chlorinated corticosteroid molecule with multiple ester groups and hydroxyl functional groups.*

FDA Label Image

Figure F (Image 10)

Illustration showing how to open the mouthpiece cover of the QVAR REDIHALER inhaler by lifting it upwards with one hand while holding the body of the inhaler with the other hand.*

FDA Label Image

Teva Logo (Image 11)

FDA Label Image

Figure 1 (Image 2)

A line graph depicting FEV1 (change from baseline in liters) over time in weeks for QVAR REDIHALER at doses of 80 mcg/day and 160 mcg/day compared to placebo. The graph shows data points at baseline, 2, 4, 8, and 12 weeks with error bars. Both QVAR REDIHALER doses show a greater increase in FEV1 over placebo across the time points.*

FDA Label Image

Figure 2 (Image 3)

A line graph comparing FEV1 change from baseline (L) over time in weeks for QVAR REDIHALER 320 mcg/day, QVAR REDIHALER 640 mcg/day, QVAR MDI 320 mcg/day, and placebo. The graph includes error bars and shows measurements at baseline, 2, 4, and 6 weeks.*

FDA Label Image

Teva Respiratory Logo (Image 4)

FDA Label Image

Figure A (Image 5)

An instructional illustration of the QVAR REDIHALER showing labeled parts: Vent, Mouthpiece, and White Cap. The drawing highlights the inhaler's components and their positions for user guidance.*

FDA Label Image

Figure B (Image 6)

Illustration showing the QVAR REDIHALER dose counter display. It indicates 'Inhaler Full' at 120 doses and 'Inhaler Empty' at 0 doses. The image highlights the dose counter on the inhaler mouthpiece, used to track remaining doses during use.*

FDA Label Image

Figure C (Image 7)

An instructional illustration showing hands opening or preparing the QVAR REDIHALER device, with an arrow indicating a rotating or clicking motion, accompanied by the word 'Click!' to demonstrate the action needed for device use.*

FDA Label Image

Figure D (Image 8)

An instructional illustration showing hands opening the cover of a QVAR REDIHALER inhaler. The image depicts the motion of flipping down the inhaler cap, indicated by a curved arrow, to prepare the device for use.*

FDA Label Image

Figure E (Image 9)

An instructional diagram showing a person using a QVAR REDIHALER inhaler. The image illustrates holding the inhaler close to the mouth with the mouthpiece inserted between the lips, demonstrating proper inhalation technique with an arrow indicating inhalation direction.*

FDA Label Image

Label Image (Lbl530022436)

QVAR 40MCG HFA REDIHALER label showing the product name and dosage strength. The label indicates it is an inhalation aerosol for inhaling 1 puff twice a day or as directed. It includes fields for patient name, prescriber, clinic information, along with lot number, expiration date, barcode, NDC numbers, and distributor details. The label is from RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530023477)

QVAR REDIHALER 80MCG HFA (120) inhaler label from RPK Pharmaceuticals, Inc. The label indicates the product is an inhalation aerosol with 80 mcg strength, providing 120 actuations. Directions include using 1 puff twice a day or as prescribed. Additional instructions and patient information are printed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.